TINA REICHLEY: Open Payments
NPI 1811982887 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 42 payments from 12 companies in 2025. Trend: 2023 $533 · 2024 $595 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $192 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| Abbott Laboratories | 3 | $56 |
| Novo Nordisk Inc | 3 | $52 |
| Exact Sciences Corporation | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Astellas Pharma US Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, QULIPTA, FREESTYLE LIBRE 3, Ozempic, FARXIGA, CAPLYTA, UBRELVY, The Cologuard Plus Collection Kit.
Industry payments across IN — which companies pay providers there.
